StonvexLoading…
StonvexStonvexStonvexCore line items from WAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.10B | $943.55M | $791.01M | $704.87M |
Operating Income | $249.31M | $123.72M | $142.08M | $89.45M |
Net Income | $112.09M | $-19.13M | $-51.33M | $-51.45M |
EPS (Diluted) | $0.61 | $-0.13 | $-0.42 | $-0.42 |
Total Assets | $5.79B | $4.58B | $4.58B | Not available |
Total Liabilities | $1.91B | $1.50B | $2.53B | Not available |
Cash & Equivalents | $61.35M | $182.13M | $35.58M | $64.56M |
Free Cash Flow OCF − CapEx | $283.19M | $142.50M | $29.94M | $85.20M |
Shares Outstanding | 191.59M | 172.11M | 121.68M | 121.68M |